
IMD-Pharma
Primary tabs
About your organization / profile
IMD-Pharma S.A.S is a french biotechnology company conducting research and development of innovative drug candidates for immune-related inflammatory diseases.
http://www.imd-pharma.com/
Advisory board:
Marc Cluzel, MD – Founder of C&F Consulting - Former Head of Global R&D at Sanofi
Claude Allary, PhD - Founder of Bionest Partners.
Jacques Peuscet, IP attorney (more 30 years as patent attorney, IP attorney for l’Oréal).
Alexis Denis, PhD - Director Discovery at Oncodesign: Broad range of experience in R&D and Medchem (Aventis, Pfizer, Mutabilis, GSK).
Pierre Gressens, MD, PhD - Professor of Perinatal Neurology at Hammersmith Hospital, Imperial College of London, and Director of the INSERM U676 research center (perinatal neurology): researcher and child neurologist at Robert Debré Hospital, Paris, since 1995.
Alexandre Prat, MD, PhD - Full Professor, Department of Neurosciences (Université de Montréal), Director of Neuroimmunology Research Laboratory (CRCHUM), Physician atthe Division of Neurology (CHUM), Canada Research Chair in Multiple Sclerosis
Network (0)
There are no organizations in the network.